These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27075102)

  • 1. The tumour trail left in blood.
    Chi KR
    Nature; 2016 Apr; 532(7598):269-71. PubMed ID: 27075102
    [No Abstract]   [Full Text] [Related]  

  • 2. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
    Abbosh C; Birkbak NJ; Wilson GA; Jamal-Hanjani M; Constantin T; Salari R; Le Quesne J; Moore DA; Veeriah S; Rosenthal R; Marafioti T; Kirkizlar E; Watkins TBK; McGranahan N; Ward S; Martinson L; Riley J; Fraioli F; Al Bakir M; Grönroos E; Zambrana F; Endozo R; Bi WL; Fennessy FM; Sponer N; Johnson D; Laycock J; Shafi S; Czyzewska-Khan J; Rowan A; Chambers T; Matthews N; Turajlic S; Hiley C; Lee SM; Forster MD; Ahmad T; Falzon M; Borg E; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Hafez D; Naik A; Ganguly A; Kareht S; Shah R; Joseph L; Marie Quinn A; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Oukrif D; Akarca AU; Hartley JA; Lowe HL; Lock S; Iles N; Bell H; Ngai Y; Elgar G; Szallasi Z; Schwarz RF; Herrero J; Stewart A; Quezada SA; Peggs KS; Van Loo P; Dive C; Lin CJ; Rabinowitz M; Aerts HJWL; Hackshaw A; Shaw JA; Zimmermann BG; ; ; Swanton C
    Nature; 2017 Apr; 545(7655):446-451. PubMed ID: 28445469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating cell-free DNA as biomarker for cancer *header*].
    Isomursu A; Kononen J; Kuopio T
    Duodecim; 2015; 131(5):424-32. PubMed ID: 26237904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Biopsies in Oncology and the Current Regulatory Landscape.
    Strotman LN; Millner LM; Valdes R; Linder MW
    Mol Diagn Ther; 2016 Oct; 20(5):429-36. PubMed ID: 27324559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
    Seiden M; Sklar JL
    Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
    [No Abstract]   [Full Text] [Related]  

  • 8. Research progress on liquid biopsy in oncology and its clinical applications.
    Wang C; Li YM; Fang XD
    Yi Chuan; 2017 Mar; 39(3):220-231. PubMed ID: 28420618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsy - The Non-invasive Tool for Tracking Cancer.
    Baig S; Jafarey O
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):417-418. PubMed ID: 29848413
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer screening fantasies].
    Jordan B
    Med Sci (Paris); 2017 Apr; 33(4):441-444. PubMed ID: 28497741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going With the Flow: The Promise and Challenge of Liquid Biopsies.
    Friedrich MJ
    JAMA; 2017 Sep; 318(12):1095-1097. PubMed ID: 28885642
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.
    Cree IA
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1067-1072. PubMed ID: 27494709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preface.
    Makowski GS
    Adv Clin Chem; 2018; 83():ix. PubMed ID: 29304905
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinguishing de novo second cancer formation from tumor recurrence: mutational fingerprinting by microdissection genotyping.
    Rolston R; Sasatomi E; Hunt J; Swalsky PA; Finkelstein SD
    J Mol Diagn; 2001 Nov; 3(4):129-32. PubMed ID: 11687595
    [No Abstract]   [Full Text] [Related]  

  • 16. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer DNA in the Circulation: The Liquid Biopsy.
    Husain H; Velculescu VE
    JAMA; 2017 Oct; 318(13):1272-1274. PubMed ID: 28973237
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
    Cabel L; Proudhon C; Mariani P; Tzanis D; Beinse G; Bieche I; Pierga JY; Bidard FC
    Eur J Surg Oncol; 2017 May; 43(5):949-962. PubMed ID: 28185687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer therapy: an evolved approach.
    Willyard C
    Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.